Alneed Gold Capsule
Each capsule contains-
- Elemental Iron 50 mg (as Carbonyl Iron)
- Folic Acid 0.50 mg
- Thiamine Mononitrate 2 mg
- Riboflavin 2 mg
- Pyridoxine Hydrochloride 1 mg
- Nicotinamide 10 mg,
- Vitamin C (as Ascorbic Acid) 50 mg
- Zinc Sulphate Monohydrate 61.80 mg
This is a haematinic preparation with vitamins and minerals.
- Carbonyl Iron is more effective and safer choice of Iron supplementation as it has higher bioavailability, low toxicity and better GI tolerance.
- Folic acid is required to maintain normal healthy development of the neural tube and is vital for cell division from a single cell to a fully developed baby.
- Vitamin B Complex is required for the growth and development of unborn babies.
- Vitamin C plays a role in the structure of collagen in the fetal membrane.
- Zinc is a critical nutrient for fetal growth & development, central nervous system development & function and ensures better maternal & infant health.
It is used for the treatment and prophylaxis of Iron, Folic Acid, Vitamin B Complex, Vitamin C and Zinc deficiency especially during pregnancy and lactation. It is also used for the geriatric patients with generalized weakness due to vitamins and minerals deficiency.
|Trade Name||Alneed Gold|
|Generic||Carbonyl Iron + FolicAcid + Vitamin-B Complex + Vitamin C + Zinc Sulphate Monohydrate|
|Therapeutic Class||Iron, Vitamin & Mineral Combined preparation|
|Manufacturer||Incepta Pharmaceuticals Limited, Incepta Pharmaceuticals Ltd|
|Available Country||Bangladesh, India|
|Last Updated:||June 23, 2021 at 11:17 am|
Table Of contents
Alneed Gold dosage
Adult: One Capsule daily before food or as directed by the physician.
Gastrointestinal irritations such as nausea, anorexia, vomiting, discomfort, constipation and diarrhoea may occur. Patients may complain of dark stool. Carbonyl Iron pellets incorporated into the capsules to reduce the possibility of gastrointestinal irritations. Rarely there may be allergic reactions.
Special care should be taken in patients with Iron overload states, such as haemochromatosis, haemolytic anaemia or red blood cell aplasia. Failure to response to the treatment requires further investigations to exclude other causes of anaemia. In patients with renal failure there may be the risk of Zinc accumulation.
Carbonyl Iron decreases the absorption of tetracycline antibiotics, quinolone antibiotics, levodopa, levothyroxine, methyldopa and penicillamine. Folic Acid interacts with antiepileptics, so plasma concentrations of phenobarbital, phenytoin and primidone are possibly reduced.
Pregnancy & Breastfeeding use
Use of any drug during first trimester of pregnancy should be avoided if possible. Thus administration of Iron during the first trimester requires definite evidence of Iron deficiency. Prophylaxis of Iron deficiency where inadequate diet calls for supplementary Zinc and Folic acid is justified during the remainder of pregnancy.
It is contraindicated in patients with known hypersensitivity to any of its component or those with Iron overload.
Symptoms of Carbonyl Iron include decreased energy, nausea, abdominal pain, tarry stool, weak, rapid pulse, fever, coma, seizures.
Store in a cool and dry place, keep away from light and moisture. Keep all medicines out of the reach of children.